New Insight Into Metformin Action: Regulation of ChREBP and FOXO1 Activities in Endothelial Cells

Metformin has been considered a potential adjunctive therapy in treating poorly controlled type 1 diabetes with obesity and insulin resistance, owing to its potent effects on improving insulin sensitivity. However, the underlying mechanism of metformin's vascular protective effects remains obsc...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Endocrinol
Egile Nagusiak: Li, Xiaoyu, Kover, Karen L., Heruth, Daniel P., Watkins, Dara J., Moore, Wayne V., Jackson, Kathyrin, Zang, Mengwei, Clements, Mark A., Yan, Yun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Endocrine Society 2015
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5414702/
https://ncbi.nlm.nih.gov/pubmed/26147751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/ME.2015-1090
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak